Antidepressant Treatment and Suicidality

The summary for the Antidepressant Treatment and Suicidality grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Antidepressant Treatment and Suicidality: - The National Institute of Mental Health (NIMH) requests research applications to study the relationship between use of antidepressant medications, especially the selective serotonin reuptake inhibitors (SSRIs), and suicidality (including suicidal ideation, suicidal attempts, and suicide deaths). This RFA is designed to encourage innovative, multi-disciplinary, multi-method efforts to explore the pharmacological, psychological and social mechanisms that potentially put some individuals at greater risk for suicidality when prescribed antidepressants. - The NIMH intends to commit approximately $1.5 million in FY 2006. - The anticipated number of awards is 4-6. - This funding opportunity will use the NIH R01, R21, and R34award mechanisms. - Eligible organizations include: for-profit, non-profit, public or private institutions, such as universities, colleges, hospitals, and laboratories; units of state and local governments; eligible agencies of the Federal government; domestic institutions; foreign institutions, faith-based or community-based organizations; units of State or Local tribal government. - Eligible principal investigators include: any individuals with the skills, knowledge, and resources necessary to carry out the proposed research. - Applicants may submit more than one application, provided they are scientifically distinct. - See Section IV.1 for application materials. - Telecommunications for the hearing impaired is available at: TTY 301-451-0088